FDA Warning & Recall Information

After three recalls by the U.S. Food and Drug Administration (FDA) and the shuttering of its facility, Florida pharmaceutical company PharmaTech LLC is now the subject of seven stool softener lawsuits, several involving the death of an infant. Diocto Liquid PharmaTech LLC, the maker of […]

The U.S. Food and Drug Administration (FDA) approved Xeljanz and Xeljanz XR on November 6, 2012, and February 23, 2016, respectively. Both drugs are made by Pfizer, Inc. and were approved to treat moderate to severe active rheumatoid arthritis. Rheumatoid arthritis (RA) is the most […]

The U.S. Food and Drug Administration (FDA) approved Ocaliva (obeticholic acid) on May 31, 2016, to treat primary biliary cholangitis (PBC), a chronic liver condition resulting from destruction of the bile ducts in the liver. When the bile ducts are impaired, bile builds up in […]

The U.S. Food and Drug Administration (FDA) approved Trulicity, a type 2 diabetes drug manufactured by Eli Lilly & Company, on September 18, 2014. The drug in combination with diet and exercise is intended to improve glycemic control in adults with type 2 diabetes mellitus. […]

The U.S. Food and Drug Administration (FDA) approved Qvar (beclomethasone dipropionate hfa) on September 15, 2000, for the treatment of asthma. Qvar is a steroid manufactured by Teva Pharmaceutical Industries, Ltd. that works directly in the lungs to ease breathing by reducing the irritation and […]

The FDA warns that Latuda, a drug used to treat major depressive episodes, could lead to a serious condition called hyponatremia which occurs when water and sodium are out of balance in the body. Latuda is manufactured by Sunovion Pharmaceuticals Inc. The U.S. Food and Drug Administration (FDA) approved Latuda on October […]

The U.S. Food and Drug Administration (FDA) approved Marinol (dronabinol) on May 31, 1985, for the treatment of anorexia nervosa associated with weight loss in patients with AIDS, and chemotherapy-induced nausea and vomiting (CINV). Marinol is manufactured by Unimed Pharmaceuticals, a subsidiary of Solvay Pharmaceuticals, and is usually prescribed […]

Victoza is an injectable drug that was approved on January 25, 2010, to treat type 2 diabetes mellitus. Developed by Novo Nordisk, Victoza is similar to the natural hormone GLP-1 and helps maintain blood sugar, insulin levels, and digestion. Used with diet and exercise, the […]

The U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) capsules for the treatment of idiopathic pulmonary fibrosis (IPF) on October 15, 2014. IPF is a rare and fatal lung disease that affects as many as 132,000 patients in the U.S.  Pulmonary fibrosis is a […]

Epinephrine was approved on May 23, 1984, to treat cardiac arrest and anaphylaxis. Endo International and GeoPharma, Inc manufacture the drug. Epinephrine, also known as adrenaline, is a hormone that is secreted by the adrenal glands. Adrenalin (without the e) was originally used as a […]

The FDA approved Carafate (sucralfate) in 1981 for the short-term treatment of active duodenal ulcers. A duodenal ulcer is a sore on the upper part of the small intestine and is very common with more than 200,000 cases in the U.S. every year. Carafate, an […]

Statin drugs lower the level of cholesterol in the blood by decreasing the production of cholesterol by the liver. Statins work by blocking hydroxy-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), the enzyme in the liver that is responsible for producing cholesterol. Although cholesterol is essential to the […]